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Abstract
BACKGROUND: Bone augmentation procedures to enable dental implant placement are frequently
performed in practice. METHODS: In this session the European Workshop on Periodontology discussed
the evidence in support of the procedures and examined both adverse events and implant performance in
the augmented bone. While the available evidence improved both in quantity and quality since previous
workshops the conclusions that could be drawn were limited by elements of design and/or reporting that
are amenable to improvement. RESULTS: With regards to lateral bone augmentation, a sizable body of
evidence supports its use to enable dental implant placement. The group recognized the potential for
vertical ridge augmentation procedures to allow implant placement in clinical practice but questioned
the applicability of these data to a wider array of operators and clinical settings. With regards to sinus
floor augmentation, perforation of the sinus membrane, graft infection and graft loss resulting in
inability of implant placement were the major reported adverse events. In cases with <6 mm of residual
bone height, 17% of subjects experienced implant loss in the first 3 years following lateral window
augmentation. After trans-alveolar sinus floor augmentation 11% of subjects experienced implant loss
over 3 years. Significant research activity (both pre-clinical and clinical) was identified in the area of
growth factors-induced bone augmentation. Initial clinical trials support the potential of BMP-2.
CONCLUSIONS: Clinically, the consensus highlighted that bone augmentation procedures can fail and
that implants placed in these areas do not necessarily enjoy the high long-term survival rates of dental
implants placed in pristine sites. The consensus emphasized the research need to answer questions on:
(i) long-term performance of dental implants placed in augmented bone; (ii) the clinical performance of
dental implants placed in augmented or pristine sites; and (iii) the clinical benefits of bone augmentation
with respect to alternative treatments.
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Abstract 
Bone augmentation procedures to enable dental implant are frequently performed in 
practice. In this session the European Workshop on Periodontology discussed the 
evidence in support of the procedures and examined both adverse events and implant 
performance in the augmented bone. While the available evidence improved both in 
quantity and quality since previous workshops the conclusions that could be drawn 
were limited by elements of design and/or reporting that are amenable to 
improvement. With regards to lateral bone augmentation, a sizable body of evidence 
supports its use to enable dental implant placement. The group recognized the 
potential for vertical ridge augmentation procedures to allow implant placement in 
clinical practice but questioned the applicability of these data to a wider array of 
operators and clinical settings. With regards to sinus floor augmentation, perforation 
of the sinus membrane, graft infection and graft loss resulting in inability of implant 
placement were the major reported adverse events. In cases with less than 6 mm of 
residual bone height, 17% of subjects experienced implant loss in the first 3 years 
following lateral window augmentation. After trans-alveolar sinus floor 
augmentation 11% of subjects experienced implant loss over 3 years. Significant 
research activity (both pre-clinical and clinical) was identified in the area of growth 
factors induced bone augmentation. Initial clinical trials support the potential of 
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BMP-2. Clinically the consensus highlighted that bone augmentation procedures can 
fail and that implants placed in these areas do not necessarily enjoy the high long-
term survival rates of dental implants placed in pristine sites. The consensus 
emphasized the research need to answer questions on: i) long term performance of 
dental implants placed in augmented bone; ii) the clinical performance of dental 
implants placed in augmented or pristine sites; and iii) the clinical benefits of bone 




A common problem encountered in implant dentistry is insufficient bone quantity to 
allow implant placement according to standard procedures. 
Various clinical techniques have been developed to address these anatomical 
problems. Based on the clinical condition either allowing or preventing implant 
placement with primary stability in the deficient site, two different approaches have 
been followed. In one condition the bone is augmented in a first step and the implant 
is placed and stabilized taking advantage of the augmented alveolar bone. In the other 
condition, the available bone allows primary anchorage of the implant but leaving a 
portion of the implant surface not embedded in bone. Here, the bone can be 
augmented during the same surgical intervention. 
Frequent situations requiring alveolar bone augmentation include developmental 
defects, periodontal disease, tooth loss, bone resorption due to 
infection/inflammation, trauma. These conditions result in lack of adequate bone 
volume in horizontal and/or vertical dimension. Interventions to correct these 
conditions can be classified in lateral and vertical ridge augmentation as well as sinus 
floor elevation. With the exception of the more recent introduction of distraction 
osteogenesis, interventions to correct these situations were proposed 15-20 years ago. 
Bone augmentation has been assessed in several previous workshops (Jensen et al 
1998, Hammerle 1999, Simion 1999, ten Bruggenkate 1999, Hammerle et al. 2002, 
Fiorellini et al 2003, Wallace et al 2003, Chiapasco et al 2006, Aghaloo and Moy 
2007). 
The scope of this working group was to critically assess the available evidence with a 
special emphasis on extending and updating the consensus of the previous workshops 
in the light of recent findings. 
The group focused on methods to augment the local bone volume. Procedures aiming 
at preserving tissues and preventing their loss were not included. 
Quality & quantity of the evidence (methodological issues) 
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Since the last Workshops, the group felt that there was an increase in the amount of 
available evidence to document the performance of the considered bone 
augmentation procedures. Besides the increase in the quantity of the evidence, the 
group has also noted a progressive shift in the type of studies being reported: more 
prospective rather than retrospective studies, more controlled trials, and, in some 
occasions, randomized controlled trials. In addition, human data is becoming 
available for the new areas of distraction osteogenesis and growth factors for alveolar 
ridge augmentation. 
In spite of this important progress, interpretation of study results was in several 
occasions limited by elements of design and/or reporting that are amenable to 
improvement. 
Difficulties remain in trying to put results in context and in relation to alternative 
(control) intervention(s). Controlled trials and randomized controlled clinical trials 
are needed. While the group fully recognizes the challenges posed by these study 
designs – in particular in the field of bone augmentation – some of the most relevant 
clinical questions can best be addressed using comparative original research. 
The group identified that the important question of applicability of the evidence to 
the population, the clinical setting, the specific clinical situation, and the intervention 
need to be addressed. This should be done preferably in large-scale, multi-center 
trials. 
With regards to choice of outcomes, the group felt encouraged and supports the 
studies that have started reporting patient centered outcomes, including patient 
satisfaction, adverse events, complications and cost-benefit analyses. The group also 
commended efforts to add success (of the procedure, of the implant and of the 
implant borne restoration) to the more traditional survival analyses. 
Lateral bone augmentation (Donos et al. 2008) 
The focus question of this systematic review was to assess implant survival/success 
following different lateral ridge augmentation procedures in comparison to implants 
placed in sites with no need for lateral ridge augmentation (pristine sites). The 
techniques evaluated encompass GBR, bone grafts and ridge expansion. Both 
surgical approaches regarding timing of augmentation and implant placement, 
namely the one-stage/simultaneous approach and the two-stage/staged approach, 
were considered. 
The systematic review is based on 4 studies fulfilling the inclusion criteria. Only 
prospective studies with a control group and where functional loading of the implants 
was present for at least 6 months were included. These studies were identified from a 
search strategy that retrieved 125 publications. The conclusions are based on 3 
studies with the simultaneous approach (2 with GBR, 1 with bone substitutes alone), 
and 1 with the staged approach applying block bone grafts. In total these studies 
reported on 126 patients and 450 implants.  
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The group agrees that the data in the systematic review is the best available evidence 
relevant to answering the focused question of the comparative fate of implants and 
marginal bone loss around implants placed in regenerated or pristine bone. Because 
of the importance of the conclusions drawn by the systematic review, the group felt 
the need to examine in depth each piece of the evidence presented. In doing so the 
group felt that the significance of the findings reported in the original papers could 
not be fully captured by a formal qualitative assessment of study design but that more 
subtle elements such as the actual performance of the surgical intervention needed to 
be included. In doing so the group was not confident that conclusions comparing 
implants in regenerated bone and in pristine sites could be drawn at this time.  
Because of the large body of evidence reviewed in previous consensus conferences 
that supports the use of lateral bone augmentation procedures to enable dental 
implant placement, the group determined an important need to answer a comparative 
question in terms of marginal bone levels and implant survival. 
Vertical bone augmentation to enable dental implant placement 
(Rocchietta et al 2008) 
This review addressed the focused question of what is the predictability of vertical 
ridge augmentation techniques for patients, who were diagnosed with insufficient 
alveolar bone volume for the placement of dental implants. 
A meta-analysis was not performed due to the heterogeneity and the limited number 
of data reported. 
Techniques included guided bone regeneration (GBR), distraction osteogenesis, and 
onlay bone grafting. The initial search identified 189 papers. 7 identified articles 
reported on GBR, 13 on distraction osteogenesis, 5 on onlay bone grafting. The 
evidence comprised 460 patients with 1,334 dental implants.  
Studies on GBR procedures reported a range of vertical bone gains of 2-8mm. The 
most common complication was barrier membrane exposure and its sequelae, which 
in some patients prevented implant placement. Mean marginal bone loss at implants 
in augmented sites ranged from 1.8-2.0 mm over a 1-7 year follow-up. Dental 
implant survival rates in the augmented sites of 92.1%-100% over 1-7 years were 
reported. A broad range of incidence of complications was detected (0% to 45.5%).  
For distraction osteogenesis, the vertical bone gain reported ranged from 5 to 15 mm. 
Mean marginal bone loss at implants in augmented sites ranged from 1-1.4 mm over 
a 1-5 year follow-up. Implant survival rates ranged from 90% to 100%. However, a 
high prevalence of complications was reported (10% -75.7%) such as lingual-palatal 
inclination of the bone segments during distraction. 
For onlay bone grafting, mean gain of vertical height ranged from 4.2-4.6 mm. 
Significant resorption of the blocks was observed in one paper before implant 
placement (42 %). Mean marginal bone loss at implants in augmented sites ranged 
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from 0-4.9 mm over a 1-3 year follow-up. The overall survival rate of the implants 
ranged from 76% to 100% for the studies analyzed.  
The group recognizes the potential for vertical ridge augmentation procedures to 
allow implant placement in clinical practice. However, it was noted that the evidence 
base is circumscribed to a limited number of studies performed by few investigators. 
Hence, the applicability of these data to a wider array of operators and clinical 
settings remains unclear at this time. 
For future research in this area, it is recommended that treatment protocols involving 
more reproducible, less invasive and less technique-sensitive vertical bone 
augmentation procedures and biomaterials should be developed. Patient treatment 
factors considered important for further evaluation should also consider esthetic and 
functional endpoints.  
Lateral approach sinus floor elevation (Pjetursson et al 2008) 
The focused question of this review was to assess the survival rate of grafts and 
implants placed in sites with sinus floor elevation using the lateral approach, with a 
mean residual bone height of 6 mm or less, and to evaluate the incidence of surgical 
complications. 
The present systematic review is based on 48 papers fulfilling the inclusion criteria. 
Prospective and retrospective studies reporting on implants with a mean follow-up 
time of at least 1-year after functional loading were included. These studies were 
identified from a search strategy that retrieved 175 articles. The conclusions were 
based on a material reporting the outcomes of 12,020 implants in about 4,000 
patients. Patient based data could be retrieved from 30 papers reporting on 1,300 
patients with 4,528 implants. 
The following conclusions were drawn from this systematic review. The estimated 
annual failure rate of implants inserted in combination with sinus floor elevation was 
3.5%, translated into a 3-year implant survival of 90.1%. 
However, when failure rates was analyzed on subject level, the estimated annual 
failure increased to 6% translating into 16.6% of the subjects experiencing implant 
loss over 3 years. The annual failure rate of machined surface implants (6.9 %) was 
significantly higher than that for rough surface implants (1.2 %). Moreover, when no 
membrane was used to cover the lateral window after the grafting procedure the 
annual failure rate was significantly higher (4.0 % vs. 0.7%) compared with 
procedures performed with membrane coverage.  
When only studies reporting on rough surface implants were analyzed, the 3-year 
survival rate was 96.5%. However, when failure rates was analyzed on subject level, 
the estimated annual failure increased to 2.4% translating into 7% of the subjects 
experiencing implant loss over 3 years The high survival rate of rough surface 
implants inserted in combination with sinus floor elevation was irrespective of 
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whether autogenous particulated bone, combinations of autogenous bone and bone 
substitutes, or bone substitutes alone were utilized.  
The most frequent complication reported was the perforation of the sinus membrane 
that occurred in 19.5 % of the procedures. The mean incidence of post-operative graft 
infection was 2.9 % and graft loss resulting in inability of implant placement was 
reported in 1.9 % of cases. 
A limitation of the present review is that prospective studies with a follow-up time of 
5 years are scarce; therefore studies with shorter follow-up time and open cohort 
studies were included. However, if only prospective studies with at least 5 years of 
functional loading would have been included in this systematic review, only 3 studies 
with 126 patients and 418 implants would have fulfilled the inclusion criteria.  
Therefore, retrospective studies were also included in the analysis. As prospective 
and retrospective studies are on different levels of evidence, the results were also 
analyzed separately for the two groups of studies. The annual failure rate, however, 
did not reveal significant difference between the two groups indicating an absence of 
design effect.  
Residual bone height has frequently been cited as a significant predictor of the 
success of sinus floor augmentation and implant survival/success. The systematic 
review could not assess the impact of residual bone height due to the aggregated 
nature of the data reported in individual studies.  
Cigarette smoking is considered to have a negative prognostic effect for implant 
survival/success (Strietzel et al 2007). The present systematic review tried to assess 
the effect of cigarette smoking on sinus augmentation and the survival of implants 
inserted in association with the elevation of sinuses. The effect of smoking was 
specifically addressed in 5 studies encompassing 3’032 implants. An annual failure 
rate of 3.5 % (95 % CI: 1.8 % – 7 %) in smokers and 1.9 % (95 % CI: 1.1 % – 3.3 %) 
in non-smokers was reported. The difference failed to reach statistical significance. 
More research with more precise definition of cigarette smoking exposure is needed. 
Sinus membrane perforation was the most frequently reported complication. The 
impact of perforation on the success of the procedure and the later survival of the 
implant could not be comprehensively evaluated in this systematic review. No clear 
conclusions can be drawn at this time. Better documentation and characterization on 
the impact of this complication is warranted in future studies. 
Out of 48 studies, one reported that antibiotic prophylaxis and/or administration was 
not performed. 11 studies did not report on this important issue. From this material, 
the effect of use of antibiotics cannot be established. It seems, however, that since the 
majority of protocols reporting on this element used antibiotics, antibiotic 
prophylaxis and/or administration should be considered a part of this procedure. 
In order to evaluate the outcome of sinus floor elevation and survival of implants 
inserted in combination with sinus floor elevation prospective long-term cohort 
studies reporting on patient-based and implant-based data are needed. Those studies 
should include information on residual bone height, cigarette smoking, surgical 
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techniques, material used, post-surgical protocols, complications, implant survival, 
marginal bone levels and graft stability.  
In order to compare different surgical techniques and different materials, large scale 
randomized controlled clinical trials are needed. 
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Transalveolar sinus floor elevation (Tan et al 2008) 
The focused question of this review was to assess the survival rate of implants placed 
with transalveolar sinus floor elevation technique, and to evaluate the incidence of 
surgical and post-operative complications of the procedure:  
The present systematic review is based on 19 papers fulfilling the inclusion criteria. 
Prospective and retrospective studies reporting on implants with a mean follow-up 
time of at least 1-year of functional loading were included. These were identified 
from a search strategy that retrieved 176 articles. Conclusions were based on a 
material reporting the outcomes of 4’388 implants in 2’830 patients. 
The following conclusions were drawn from this systematic review: 
The estimated annual implant failure rate was 2.5%. This translated into a 3-year 
implant survival of 92.8%. Furthermore, subject-based analyses revealed an 
estimated annual failure of 3.7%, translating to 10.5% of the subjects experiencing 
implant loss over 3 years.   
The most frequent complication reported was the perforation of the sinus membrane 
which occurred in 3.8 % of the procedures and the mean incidence of post-operative 
graft infection was 0.8 %. 
Residual bone height has frequently been cited as a significant predictor of the 
success of transalveolar sinus floor augmentation and implant survival/success. Two 
papers retrieved in the systematic review specifically reported an increased survival 
rate as the amount of residual bone increased: better results were reported for sites 
with ≥ 5 mm of residual bone.  
Given the body of evidence available for transalveolar and lateral approach for sinus 
floor elevation the question of choice of the most appropriate procedure needs to be 
addressed. The group felt that the choice of treatment is influenced by the anatomy of 
the area as well as a number of other factors. Comparative trials, however, have yet 
to be reported. 
 
Potential of growth factors (Jung et al 2008) 
The focused question of the present systematic review was to assess the clinical, 
histological and radiographic outcome of growth factors for localized alveolar ridge 
augmentation. 
Based on the available evidence, the following growth factors were evaluated: bone 
morphogenetic protein-2 (BMP-2), bone morphogenetic protein-7 (BMP-7), 
growth/differentiation factor 5 (GDF-5), platelet-derived growth factor (PDGF), and 
parathyroid hormone (PTH). The group noted that much of the evidence available for 
craniofacial applications is limited to early stage preclinical animal studies, of which 
a total of 68 were available for evaluation. 
   6th EWP Group C 
 9 
The review process identified 6 human clinical studies (including 4 RCTs) with a 
total of 163 patients studying rhBMP-2 to promote localized ridge augmentation 
(specifically for sinus floor augmentation, extraction socket repair and lateral ridge 
augmentation). These early studies in the literature suggest good potential for 
rhBMP-2 application in terms of regeneration and decreased morbidity (as compared 
to bone autografts).  
The information available for the other growth factors have demonstrated 
encouraging early evidence for regeneration, most of these results are confined to 
lower level animal models. The refinement of relevant intraoral animal models is 
needed to better study growth factor-mediated alveolar ridge repair. Clinical and 
animal studies should address the questions regarding the clinically effective doses 
required, the adequate carrier materials needed, and the optimal release kinetics for 
the clinical applications of growth factors. 
At this time, the group concluded, that this field remains overall at an early stage of 
development as compared to other bone regenerative technologies used clinically 
(GBR, bone grafting, biomaterials, etc.). Future studies need to identify the full range 
of clinical conditions that may benefit from the application of growth factors 
including comparison to standard-of-care procedures. 
 
Recommendations for practice 
 
There is a broad base of evidence supporting the use of lateral bone augmentation 
and sinus floor augmentation to place dental implant in sites with insufficient bone 
volumes. Less evidence is available for vertical ridge augmentation. Evidence for 
growth factors is emerging. 
The consensus highlighted that bone augmentation procedures have significant and 
sometimes frequent adverse events and can fail to produce adequate bone volumes to 
allow dental implant positioning. Furthermore, available indications suggest that 
implants placed in augmented areas do not necessarily enjoy the high long-term 
survival rates of dental implants placed in pristine sites.  
In the field of bone augmentation, lots of different procedures have been advocated to 
solve a specific problem. At present the lack of comparative research makes it 
difficult to select the most appropriate procedure. 
Similarly lack of research comparing solutions based on bone augmentation 
procedures with other alternatives (e.g. the use of shorter implants in the posterior 
maxilla) does not allow evidence-based choices. 
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Recommendations for research 
Consensus participants felt that future research should capitalize on improvements in 
study design and reporting that were noted since more recent workshops. Further 
efforts need to be made to ensure that (surgical) interventions satisfy accepted 
methodological standards and are adequately validated before they are used in the 
assessment of new technologies or approaches.  
The consensus emphasized the research need to: 
1. gather long term data on the performance of dental implants placed in 
augmented bone using both true outcomes (including patient outcomes) and 
validated surrogate outcomes to capture early changes relevant to implant 
success/survival 
2. answer comparative questions to establish the clinical benefits of bone 
augmentation with respect to alternative treatments 
3. compare the clinical performance of dental implants placed in augmented or 
pristine sites 
4. compare different techniques in terms of effectiveness, adverse effects, long-
term outcomes, morbidity, patient satisfaction and cost and do so in the context 
of patient age and needs. In order to do so, efforts should be made to identify 
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